$119.78
Novo Nordisk is a biotechnology business based in the US. Novo Nordisk shares (NVO.US) are listed on the NYSE and all prices are listed in US dollars. Its last market close was $2,024.00 – the same closing value as a week prior. Novo Nordisk employs 69,260 staff and has a trailing 12-month revenue of around $258.
How to buy shares in Novo Nordisk
- Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
- Fund your account. Add money to your account via bank transfer, debit card or credit card.
- Search the platform by ticker symbol. NVO in this case.
- Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
- Submit the order. It's that simple.
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
- 6% cash rebate plus $2,200 in trading perks
- Low transaction fees
- Easy-to-use app
Is it a good time to buy Novo Nordisk stock?
Review technicals and fundamentals to help you determine if now's a good time for you to invest.
Technical analysis
View Novo Nordisk's price performance, share price volatility, historical data and technicals.
Historical closes compared with the last close of $2024-10-14
1 week (2024-10-07) | 1,626.96% |
---|---|
1 month (2024-09-13) | |
3 months (2024-07-14) | 1,331.50% |
6 months (2024-04-14) | 1,533.58% |
1 year (2023-10-13) | |
2 years (2022-10-13) | 2.74% |
3 years (2021-10-14) | 1,877.72% |
5 years (2019-10-14) | 3,757.44% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Is Novo Nordisk under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Novo Nordisk P/E ratio, PEG ratio and EBITDA.
Novo Nordisk's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, Novo Nordisk's stocks trade at around 40x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Novo Nordisk's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.7905. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Novo Nordisk's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Novo Nordisk's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $126.6 billion ($174.7 billion CAD).
The EBITDA is a measure of Novo Nordisk's overall financial performance and is widely used to measure a its profitability.
Frequently asked questions
More on investing
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…What are stocks?
Owning a stock means you own part of a company and can potentially grow your wealth. But there is a risk of loss.
Read more…More guides on Finder
-
How to buy Yoshitsu Co. stock in Canada
Steps to owning and managing Yoshitsu Co. stocks, with 24-hour and historical pricing before you buy.
-
How to buy Cerberus Cyber Sentinel stock in Canada
Steps to owning and managing Cerberus Cyber Sentinel stocks, with 24-hour and historical pricing before you buy.
-
How to buy Fresh Grapes LLC stock in Canada
Steps to owning and managing Fresh Vine Wine, Inc stocks, with 24-hour and historical pricing before you buy.
-
How to buy Quest Diagnostics Incorporated stock in Canada
Steps to owning and managing DGX with 24-hour and historical pricing before you buy.
-
How to buy Nuvectis Pharma (NVCT) stock in Canada when it goes public
Everything we know about the Nuvectis Pharma IPO plus information on how to buy in.
-
How to buy BuzzFeed stock in Canada
Steps to owning and managing BuzzFeed, Inc stocks, with 24-hour and historical pricing before you buy.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Can I buy AeroFarms stock?
A failed SPAC deal pulled the plug on this vertical farming company’s plans to go public. But you can buy stock in other sustainable farming companies.
-
How to buy Reddit stock in Canada when it goes public
Everything we know about the Reddit IPO plus information on how to buy in.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.